Malaysia will decide on the use of the AstraZeneca vaccine for Covid-19 following a report by the European Medicines Agency (EMA) of rare blood clots being a possible side-effect, Science, Technology and Innovation Minister Khairy Jamaluddin said on Thursday (April 8).